AI Theatre Session: Panel Discussion

AI-SC 20 - The regulatory landscape: navigating regulatory clearance, reimbursement, and liability

March 7, 14:45 - 15:45 CET

5 min
Chairperson's introduction
36 min
Panel discussion
  1. To clarify current FDA regulatory pathways for AI/ML-based medical devices.
  2. To discuss evolving reimbursement models for AI-augmented radiology services.
  3. To address medicolegal considerations and liability distribution between radiologists, institutions, and AI vendors.
  4. To explore international regulatory harmonization efforts.
  5. To examine the role of continuous learning algorithms and post-market surveillance.
10 min
Q&A: Untangling regulation, payment and risk in AI radiology